Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Prevention and treatment of benign prostatic hyperplasia using a selective inhibitor of the production of reactive oxygen species of mitochondrial origin

Prevention and treatment of benign prostatic hyperplasia using a selective inhibitor of the production of reactive oxygen species of mitochondrial origin

US Patent 11400073 · Granted Aug 2, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for drying an impregnated blank and associated manufacturing method, syst2025
Prevention of the risks associated with drug-induced QT interval prolongation by2023
Desmethylanethole trithione derivatives for the treatment of diseases linked to 2022
Compounds for the treatment of diseases linked to mitochondrial reactive oxygen 2022
Compounds for the treatment of diseases linked to mitochondrial reactive oxygen 2020
Compounds for the treatment of diseases linked to mitochondrial reactive oxygen 2019
Heat treatment oven with inductive heating2014
Sealing device for a gas inlet to an oven or the like2009